Repolarization of macrophages from M2 to M1 was also achieved using self-assembled dual-inhibitor-loaded nanoparticles to target CSF-1 and Src homology 2 domain-containing phosphatase 2 pathways, which resulted in anti-tumor efficacy in mammary and melanoma pre-clinical mouse models [224]. The gene discussed is CSF1; the disease is neoplasm.